首页 › 胶质母细胞瘤 › 哥伦比亚特区 › Washington
Washington DC 胶质母细胞瘤临床试验
15项针对 胶质母细胞瘤的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
招募中观察性研究
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Children's National Medical Center, Washington D.C.
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期 I 期欢迎健康志愿者
- Children's National Medical Center, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
招募中1 期
- Children's National Hospital, Washington D.C.
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
招募中1 期
- Children's National Hospital, Washington D.C.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- Sibley Memorial Hospital, Washington D.C.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
招募中1 期
- National Institutes of Health, Bethesda · 距离 7 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Silver Spring · 距离 7 英里
- Massive Bio SYNERGY-AI site, Bethesda · 距离 7 英里
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
招募中1/2 期
- Sibley Memorial Hospital, Washington D.C.
其他城市的 胶质母细胞瘤试验
- New York City, NY30 项研究
- Boston, MA28 项研究
- Houston, TX26 项研究
- Los Angeles, CA24 项研究
- Durham, NC20 项研究
- San Francisco, CA17 项研究
- Chicago, IL15 项研究
- Columbus, OH14 项研究
- Miami, FL14 项研究
- Rochester, MN13 项研究
- Jacksonville, FL13 项研究
- Aurora, CO12 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 卵巢癌23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。